Colicin Immunity Protein: Difference between revisions
From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
| Line 24: | Line 24: | ||
'''Immunity proteins''' against [[Colicin]]s (EcCIP) are produced by ''E. coli'' alongside the relevant colicin protein (EcCol) to protect the cell from the cytotoxic domain of the colicin. Usually this involves binding to and blocking the active site of the domain, to prevent it from targeting the cells own mechanisms. | '''Immunity proteins''' against [[Colicin]]s (EcCIP) are produced by ''E. coli'' alongside the relevant colicin protein (EcCol) to protect the cell from the cytotoxic domain of the colicin. Usually this involves binding to and blocking the active site of the domain, to prevent it from targeting the cells own mechanisms. | ||
Once released from the producing cell, the immunity proteins are no longer needed, as the cytotoxic domain needs to be active once a target cell has been penetrated. Often it is disassociated from the colicin upon binding to an outer membrane receptor on the target cell. Find more details in [[Iia]]; [[Imm]]; [[ImmE1]]; [[Im2]]; [[Im3]]; [[Im4]]; [[ImmE5]]; [[ImmE6]]; [[Im7]]; [[Colicin Immunity Protein 7]]; [[Im8]]; [[Im9]]; [[Colicin Immunity Protein 9]]; [[ImmD]]. | Once released from the producing cell, the immunity proteins are no longer needed, as the cytotoxic domain needs to be active once a target cell has been penetrated. Often it is disassociated from the colicin upon binding to an outer membrane receptor on the target cell. Find more details in [[Iia]]; [[Imm]]; [[ImmE1]]; [[Im2]]; [[Im3]]; [[Im4]]; [[ImmE5]]; [[ImmE6]]; [[Im7]]; [[Colicin Immunity Protein 7]]; [[Im8]]; [[Im9]]; [[Colicin Immunity Protein 9]]; [[Mutant immunity protein 9 (variant R12-13)]]; [[Mutant immunity protein 9 (variant R12-2)]]; [ImmD]]. | ||
{{TOC limit|limit=2}} | {{TOC limit|limit=2}} | ||
{{Clear}} | {{Clear}} | ||
